Thus, one of the main challenges for the next decades will be to unravel the complex interactions between aging and diabetes that result in insulin resistance, allowing the development of more efficient preventive and therapeutic strategies to overcome age-related diseases (e.g., Alzheimer's disease (AD)). This evidence concerns the gene INS and early-onset autosomal dominant Alzheimer disease.